Simcere Diagnostics Overview
- Year Founded
-
2026
- Status
-
Private
- Latest Deal Type
-
Seed
- Investors
-
13
Simcere Diagnostics General Information
Description
Provider of precision diagnostics solutions intended for early disease screening, accurate diagnosis, and personalized treatment. The company leverages advanced biotechnology and big data analytics to deliver diagnostic products and data-driven insights, enabling medical institutions and patients to achieve improved clinical outcomes and tailored healthcare solutions.
Contact Information
Corporate Office
- Floors 1 & 2, Building 9, Juhuiyuan
- Number 71 Longshan North Road, Jiangbei New District
- Nanjing, Jiangsu
- China
Corporate Office
- Floors 1 & 2, Building 9, Juhuiyuan
- Number 71 Longshan North Road, Jiangbei New District
- Nanjing, Jiangsu
- China
Simcere Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 01-Jun-2026 | Completed | Startup |
Simcere Diagnostics Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CITIC Medical & Heath Group | Corporation | Minority | ||
| CITIC Securities | Investment Bank | Minority | ||
| Hangzhou Hongcheng Capital | Growth/Expansion | Minority | ||
| Hangzhou Industrial Investment Group | Government | Minority | ||
| Hony Capital | PE/Buyout | Minority |
Simcere Diagnostics FAQs
-
When was Simcere Diagnostics founded?
Simcere Diagnostics was founded in 2026.
-
Where is Simcere Diagnostics headquartered?
Simcere Diagnostics is headquartered in Nanjing, China.
-
What industry is Simcere Diagnostics in?
Simcere Diagnostics’s primary industry is Diagnostic Equipment.
-
Is Simcere Diagnostics a private or public company?
Simcere Diagnostics is a Private company.
-
What is Simcere Diagnostics’s current revenue?
The current revenue for Simcere Diagnostics is .
-
Who are Simcere Diagnostics’s investors?
CITIC Medical & Heath Group, CITIC Securities, Hangzhou Hongcheng Capital, Hangzhou Industrial Investment Group, and Hony Capital are 5 of 13 investors who have invested in Simcere Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process